In order to quantify the strength of the circadian clock in lung cancer, we used the shared mammalian circadian gene list (Table 3) to assign potential circadian times to 51 temporally unannotated healthy human lung tissue samples from the TCGA-LUAD study. This evidence concerns the gene CLOCK and lung carcinoma.